Elixinol Wellness (ASX:EXL) FCF Margin % : -44.87% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Elixinol Wellness's Free Cash Flow for the six months ended in Dec. 2023 was A$-2.16 Mil. Elixinol Wellness's Revenue for the six months ended in Dec. 2023 was A$4.81 Mil. Therefore, Elixinol Wellness's FCF Margin % for the quarter that ended in Dec. 2023 was -44.87%.

As of today, Elixinol Wellness's current FCF Yield % is -53.33%.

The historical rank and industry rank for Elixinol Wellness's FCF Margin % or its related term are showing as below:

ASX:EXL' s FCF Margin % Range Over the Past 10 Years
Min: -228.86 Med: -134.31 Max: -27.36
Current: -33.56

During the past 6 years, the highest FCF Margin % of Elixinol Wellness was -27.36%. The lowest was -228.86%. And the median was -134.31%.

ASX:EXL's FCF Margin % is ranked worse than
82.96% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.03 vs ASX:EXL: -33.56

Elixinol Wellness FCF Margin % Historical Data

The historical data trend for Elixinol Wellness's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness FCF Margin % Chart

Elixinol Wellness Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-228.86

-152.89

-153.81

-115.72

-33.56

Elixinol Wellness Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial							-136.13	-165.98	-73.61	-17.80	-44.87

Competitive Comparison of Elixinol Wellness's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elixinol Wellness's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's FCF Margin % falls into.

Elixinol Wellness FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Elixinol Wellness's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-2.775	/	8.269
	=	-33.56 %

Elixinol Wellness's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-2.16	/	4.814
	=	-44.87 %

Elixinol Wellness FCF Margin % Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Elixinol Wellness (ASX:EXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

ELLXF:USA

Address

680 George Street, Level 12, Sydney, NSW, AUS, 2000

Website

https://www.elixinolwellness.com

Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines